Early-animals studies in 2001 showed that salicylates could reverse obesity-associated insulin resistance in both genetically obese and diet-induced obese mice (68, 69), which resulted in decreased NF-κB activation. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.